Cyclic GMP-AMP Synthase in Cancer Prevention

Weidong Chen; Ga-Eun Lee; Dohyun Jeung; Jiin Byun; Wu Juan; Yong-Yeon Cho

doi:10.15430/JCP.2023.28.4.143

Cyclic GMP-AMP Synthase in Cancer Prevention

J Cancer Prev. 2023 Dec 30;28(4):143-196. doi: 10.15430/JCP.2023.28.4.143.

Authors

Weidong Chen^{1

2}, Ga-Eun Lee^{1

2}, Dohyun Jeung^{1

2}, Jiin Byun^{1

2}, Wu Juan^{1

2}, Yong-Yeon Cho^{1

2}

Affiliations

¹ BK21-Four, College of Pharmacy, The Catholic University of Korea.
² RCD Control Material Research Institute, The Catholic University of Korea, Bucheon, Korea.

Abstract

Cyclic GMP-AMP (cGAMP), synthesized by cGAMP synthase (cGAS), serves as a secondary messenger that modulates various cellular processes, including cell proliferation, cell death, immune response, and inflammation. cGAS is activated upon detecting cytoplasmic DNA, which may originate from damaged genomic and mitochondrial DNA or from viral and bacterial infections. The presence of DNA in the cytoplasm can trigger a substantial inflammatory reaction and cytokine production via the cGAS-STING signaling pathway. Consequently, specific inhibitors targeting this pathway hold significant potential as chemopreventive agents. In this review, we explore the potential effectiveness of modulating cGAS activity. We discuss the role of cGAMP, the mechanism of action for distinguishing between self and foreign DNA, and the possible functions of cGAS within the nucleus.

Keywords: Cell death; Cell proliferation; Chemoprevention; Immune response; Inflammation.

Publication types

Review

Grants and funding

FUNDING This research was funded by the Research Fund of the Ministry of Science, ICT, and Future Planning (Grant no. NRF-2023R1A2C2003059).